Anjiming Medical
安捷明
Anjiming Medical
Biotech/Healthcare
Anjieming develops equipment for the early diagnosis of glaucoma. Its CID contact-based corneal analysis system uses dynamic measurement and analysis to assess multiple biomechanical properties through changes in the cornea, correct existing intraocular pressure measurement methods, determine true…
Latest round: Pre Series A (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.